{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ7f8LIJDA","lastupdate":"2024-04-11T00:00:00.000Z","update_date":"2024-04-11T00:00:00.000Z","lastModified":"Aug 5, 2025","active":1,"confidence_score":90,"confidence_score_reason":"markets, not claimed","urlname":"interna-therapeutics","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$wD6ezNFkXzBkFrUNz5UEa6CoCXRREij1ZnsGyEdREfEa0UyMuJNAsf","name":"Interna Therapeutics","oneliner":"Drug Delivery via Electrical Nano Motors","registrar":"512380296","website":"https://interna.bio","careerspage":"","founded_month":10,"founded_year":1996,"formernames":["NST"],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/user/Aposense","facebook":"","linkedin":"https://www.linkedin.com/company/1833144","instagram":""},"social":["https://www.linkedin.com/company/1833144","https://www.youtube.com/user/Aposense"],"flattenedsociallinks":"https://www.linkedin.com/company/1833144|https://www.youtube.com/user/Aposense","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":19,"patent":1,"raised":57550000,"stage":"Mature","public_stage":"Mature","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["ATT"],"about":"Interna Therapeutics is an innovative biotechnology company that developed a transformational delivery technology for macromolecules. \n \nThe pioneering technology, named Molecular Nano-Motors (MNMs), is based on a novel mechanism that leverages membrane electrical forces, facilitating entry of charged molecules into cells. With this technology new treatment options become available for a wide range of diseases using difficult to deliver molecules such as oligonucleotide-based drugs (siRNA, ASO).\n \nEquipped with full-capacity research facilities and working with leading research organizations, the team of seasoned scientists has demonstrated the therapeutic potential of MNM technology in numerous preclinical studies, with a Phase I study of a COVID-19 drug that began in September 2024.\n \nInterna’s innovative spirit and scientific excellence has been recognized by key opinion leaders in the pharma industry and by non-governmental organizations.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+972732397600","country":null,"address":{"israeli":[{"id":"e44c495c-4326-4e93-b0a3-74fb8b485f75","city":"Petah Tikva","type":null,"address":"Odem St 5-7, Petah Tikva, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"rW13mVZBan3lV7jXi02VTRvpt6Y4Eyzk5KXr7rg6pja2XQH3qp7B11","date":"Mar 30, 2021","link":"https://finance.yahoo.com/news/bioasis-technologies-inc-aposense-enter-200500614.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Partnership, Research Collaboration","company":"Bioasis Technologies Inc.","layoffs":"N/A","summary":"Bioasis Technologies Inc., a biopharmaceutical company, has announced a research collaboration with Aposense Limited, an Israeli bio-pharmaceutical company. The collaboration will focus on the delivery of siRNA into the brain, a challenging task due to the blood-brain barrier. Bioasis has developed a technology that delivers effective treatments across this barrier, and with Aposense, they aim to progress the discovery and development of new siRNA-based drugs for serious neurological conditions.","partners":"Aposense Limited","customers":"N/A","investors":"N/A","confidence":9,"key_topics":["Research Collaboration","siRNA Therapeutics","Blood-Brain Barrier","Neurological Diseases","Drug Development"],"date_of_event":"March 31, 2021","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Partners"],"acquisition_amount":"N/A","structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"55YKHLoxAu31cuECBaTbM00nZjCmRw3CDEKUClw7777wTZ0CtGZWLB","news_summary":"Bioasis Technologies Inc. and Aposense Enter into a Research Collaboration","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"c486d844-8eee-40f3-8ba5-ea0077238f31","date":"Jun 1, 2020","link":"https://www.globenewswire.com/news-release/2020/06/01/2041568/0/en/PROCESSA-PHARMACEUTICALS-ANNOUNCES-THAT-IT-HAS-ENTERED-INTO-AN-AGREEMENT-WITH-APOSENSE-LTD-TO-LICENSE-IN-THE-NEXT-GENERATION-IRINOTECAN-DRUG.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"Partnership, Licensing, Cancer Drug","company":"Processa Pharmaceuticals, Inc.","layoffs":"Not mentioned","summary":"Processa Pharmaceuticals has signed a licensing agreement with Aposense, LTD. to develop and commercialize their next generation irinotecan cancer drug, ATT-11T. The licensing agreement is contingent upon Processas closing of the Satisfactory Financing Round and the listing of the Companys shares on the NASDAQ or NYSE and Aposense obtaining the approval of the Israel Innovation Authority. Under the terms of the License Agreement, Aposense will receive shares in Processa with an aggregate value of $2.5 M and could receive up to $125 M in potential development and sales milestones, as well as royalties of 7% based on net sales.","partners":"Aposense, LTD.","customers":"Not mentioned","investors":"Aposense, LTD.","confidence":9,"key_topics":["Licensing Agreement","Cancer Drug","Aposense","Investment","NASDAQ Listing"],"date_of_event":"June 01, 2020","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$2.5 M","structured_issues":["Partners","Investment"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"zvYpz9cwMpFpnzt2zjKOdnlS4dJOzIq60hoBnsFZQAZvnsL6U8qYiW","news_summary":"PROCESSA PHARMACEUTICALS ANNOUNCES THAT IT HAS ENTERED INTO AN AGREEMENT WITH APOSENSE, LTD TO LICENSE IN THE NEXT GENERATION IRINOTECAN DRUG","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"bc915380-0e79-4f07-99ae-d8d486d4a195","date":"Jan 9, 2019","link":"https://en.globes.co.il/en/article-aposense-unit-to-receive-20m-investment-from-len-blavatnik-1001268326","source":"en.globes.co.il","visible":1,"analysis":{"tags":"genetic therapy, infectious diseases, respiratory system","company":"Aposense Ltd.","layoffs":null,"summary":"Aposense Ltd. has announced the founding of a subsidiary named Sirvir, which will use its genetic therapy technology to develop treatments for infectious diseases in the respiratory system. The subsidiary will be jointly owned by Aposense, Access Industries Holdings LLC, and Prof. Roger Kornberg. Access Industries has committed to investing $4 million in Sirvir immediately, with the potential for an additional $16 million investment. Aposenses share price increased by 6% following the announcement. Aposense has developed a system for directing molecules into body cells to silence certain genes, which has the potential to make a significant contribution to medicine. The product is currently in laboratory testing. Access Industries is known for making direct medical investments.","partners":null,"customers":null,"investors":"Access Industries Holdings LLC","confidence":9,"key_topics":["genetic therapy","infectious diseases","respiratory system","investment","Access Industries"],"date_of_event":"January 9, 2019","valuation_amount":"NIS 20 million","impact_on_company":"growth-positive","investment_amount":"$4 million (initial investment), potential for $16 million more","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"MhVMLsD4jWUlQb837aOZC4eTXHkoviDqCyUukrOGgLyyC3KONlrLUk","news_summary":"Aposense unit to raise $20m from Len Blavatnik","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"c07d7844-4e83-436d-b585-f3946ea076fa","date":"Sep 21, 2015","link":"http://www.globes.co.il/en/article-israeli-firm-signs-research-deal-with-pfizer-1001069836","source":"www.globes.co.il","visible":1,"analysis":{"tags":"technological evaluation","company":"Aposense","layoffs":null,"summary":"Aposense and Pfizer have signed an agreement for the technological evaluation of Aposenses ML-10 molecule. The agreement carries no financial significance at this stage, but if Pfizer decides to use Aposenses technology, it could have financial repercussions for the company. Aposenses share price jumped 24.8% after the agreement was signed, increasing its market value to NIS 37 million.","partners":"Pfizer","customers":null,"investors":"Pfizer","confidence":8,"key_topics":["Aposense","Pfizer","technology","apoptosis","PCD"],"date_of_event":"September 21, 2015","valuation_amount":"NIS 37 million","impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"1uz71VY70hs1ZGbhZZINSeupOACKvWTWLOOBLobSrz9hbhmNhCeN2O","news_summary":"Israeli co Aposense jumps on research deal with Pfizer","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"9459729a-d0df-4517-b680-39ff634ca70d","date":"Jan 9, 2014","link":"http://www.globes.co.il/en/article-1000908249","source":"www.globes.co.il","visible":1,"analysis":{"tags":"biomed","company":"Aposense Ltd.","layoffs":null,"summary":"Aposense Ltd. has completed preclinical studies for the ATT-11T molecule for early stage treatment of colon cancer. The molecule is being developed in partnership with Teva Pharmaceutical Industries. Aposense has also developed an IV formula suitable for humans. The ATT-11T molecule is a combination of Irinotecan and Aposenses novel molecule designed to improve its effectiveness within the tumor. Aposense plans to submit a pre-IND application and work with the FDA to complete formal toxicology studies and initiate clinical trials later in the year.","partners":["Teva Pharmaceutical Industries"],"customers":null,"investors":"Teva Pharmaceutical Industries","confidence":8,"key_topics":["ATT-11T","colon cancer","preclinical studies","Teva Pharmaceutical Industries","Irinotecan"],"date_of_event":"January 9, 2014","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"QB0sTlPUVr3U3lHhCsuVK9tZ9uZfEgDRtZYPW9p49yuWz7ereZ3v2I","news_summary":"Aposense reports positive colon cancer drug results","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":5,"techcommunityinvolvement":null,"mediagallery":[{"id":"WouHefWnCBUiEnpC7iZGNfXXjivYh1SUsii5o6teDzFUu5AvLXIpV6","timestamp":"2024-04-11 15:47:40.000000","resources_type":3,"resources_title":"","resources_file_name":"761867313","alt":"","imageurl":"https://vumbnail.com/761867313.jpg","url":"https://vimeo.com/761867313"}],"tags":["gastroenterology","cns-disorders","pulmonary","cancer","oncology","parkinson","pharmaceuticals","drug-delivery","genetics","nanotechnology","pharma-companies"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1upgKDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["Apo-Si"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":10,"lastfunding":"$10.25M","totalrounds":5,"fundingstage":"Mature","totalfunding":"$57.55M","publicinvestors":10,"lastpublicfunding":10250000,"totalpublicrounds":5,"totalpublicfunding":57550000},"team":[{"name":"Yuval Gottenstein","email":"yuvalg@aposense.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoMmdioYIDA","bounced":false,"claimed":0,"founder":0,"urlname":"yuval-gottenstein","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgyeHEzQsM","position":"CEO","last_name":"Gottenstein","claimtoken":"I69elTAZyfxYyGi2CqTgSqBvTwfN02rA4b57PkjxjMvjJnuwTAG5OV","first_name":"Yuval","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yuval-gottenstein-18517625/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-04-11 15:47:57.000000","initials":"YG","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ilan  Ziv, MD","email":"ilan@aposense.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgNGHqYMIDA","bounced":false,"claimed":0,"founder":1,"urlname":"ilan-ziv-md","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICA8bK0tgoM","position":"Co-founder","last_name":"Ziv, MD","claimtoken":"v2r2a3oc8RdshgMy2qUFQEZ3Qp6LC8HBluAMR2wn23kOICEKEZQV9i","first_name":"Ilan ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ilan-ziv-b449a671/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-04-11 15:48:00.000000","initials":"IZ","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Carmit Lev","email":"carmit@aposense.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoKWNm5gKDA","bounced":false,"claimed":0,"founder":0,"urlname":"carmit-lev","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgpcKynQgM","position":"HR, Operations & IP Manager","last_name":"Lev","claimtoken":"996d05390bedc44f4c9bdc54f7954e52be5bca45569740dfb927f65ef6cf953a","first_name":"Carmit","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/carmit-lev-89999b36/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-08-17 07:27:41.000000","initials":"CL","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverifydate":"2019-11-20T00:00:00.000Z","crunchbaseid":"aposense","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Jenny Sotnik-Talisman","creator_email":"genys30@yahoo.com","createdate":"2014-07-07T00:00:00.000Z","biverification":"Sharon Shapira","sectorverification":"Natalia Golczar","affiliatedOrganizations":null,"timeline":[{"id":"O4tCXSWssrMZzssapMmqocje17PqOCvbFIdcEy8C7VgHwjCiKy1Xoj","date":"Nov 2024","amount":"Undisclosed","source":"https://interna.bio/news/needs-authorization-aposense-ltd-secures-10-25-million-funding-round-anchored-by-the-bill-melinda-gates-foundation-announces-merger-with-sirvir-and-name-change-to-interna-therapeuti/","mnatype":"Merger","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"acquiredcompany_mna":"SirVir","acquiredcompany_mna_id":"Qr348JTfPan2SFu8hgnF9teoA3jrZfY5uwKL6oYwkev8rmB0eVKQXX","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/company_page/sirvir","acquiredcompany_mna_logokey":null,"acquiredcompany_mna_urlname":"/company_page/sirvir","acquiredcompany_mna_homepage":"https://aposense.com","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"/assets/empty-state.svg","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"Q2reUP4PCDJTlLh6fKQCLdiRTP5W11L94MmcoQldCy2HBrtKpHhS0v","date":"Nov 2024","amount":"$10.25M","source":"https://interna.bio/news/needs-authorization-aposense-ltd-secures-10-25-million-funding-round-anchored-by-the-bill-melinda-gates-foundation-announces-merger-with-sirvir-and-name-change-to-interna-therapeuti/","eventtype":"FundingRoundEvent","investment":[{"name":"Bill & Melinda Gates Foundation","type":"Investor","amount":null,"hidden":true,"country":"United States","fullurl":"/investor_page/bill-melinda-gates-foundation-1","logokey":"$p9OelZpbjDTmXC8KXIygAeGkMhOLMYJveju2NbDuZZcXFsP9YIzsEZ.png","tagline":null,"urlname":"/investor_page/bill-melinda-gates-foundation-1","isisraeli":0,"investorid":"59efOBYCZP6VtEgRf9VLpGtlh1KIGD0iqOP0HT0tHj9gxO9ipMI5nC","fundingtype":"Grant Provider","leadpartner":null,"investmentid":"5SNYhMhLfU5b6Ax8aKju0bCaXwPJrX75ZatrSTFQ0RtpqQ9EyuTrCB","fundingsubtype":"Grant Provider","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$p9OelZpbjDTmXC8KXIygAeGkMhOLMYJveju2NbDuZZcXFsP9YIzsEZ.png","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10250000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"1rFJEZ4RoQFF2h9xu81iR3I0Py0BiWShfutoqh428PE1iXBf6WfQBq","date":"Aug 2019","amount":"Undisclosed","source":"https://www.tase.co.il/en/market_data/company/1545/securities/delisted","ticker":null,"eventtype":"DelistingEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"","po_label":"Public Offering","duetoacquisition":"","isdelisting":1,"acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":null,"valuationnumber":null},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODwxM_WCgw","date":"Jun 2010","amount":"Undisclosed","source":"","ticker":"APOS","eventtype":"POEvent","valuation":"$238M","investment":[],"capitalraised":"$25M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":25000000,"valuationnumber":238000000},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEu6DRCww","date":"May 2010","amount":"$3M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Ziegler Meditech Equity Partners","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/ziegler-meditech-equity-partners","logokey":"$nHMD96loNRn3C8Dcro3zz5Kiq8aEFkqJhlDx6bFQoAyS2dQgOra0Dn","tagline":null,"urlname":"/investor_page/ziegler-meditech-equity-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLWByYgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"b19fe67a-29ce-4e13-a480-45db20eedf07","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nHMD96loNRn3C8Dcro3zz5Kiq8aEFkqJhlDx6bFQoAyS2dQgOra0Dn","leadcaption":"","followupcaption":"Follow on "},{"name":"Pontifax","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/Pontifax","logokey":"$8HWp0ziD5Hcmj6wqEIHQTrElz5KthIPEOZM39F7kKUQRFzC0JbmnmH","tagline":null,"urlname":"/investor_page/Pontifax","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOfWjoAKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"d80e1d18-5dac-418a-88dc-4b455d55fff8","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8HWp0ziD5Hcmj6wqEIHQTrElz5KthIPEOZM39F7kKUQRFzC0JbmnmH","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODknp7qCAw","date":"Aug 2008","amount":"$7.3M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Phoenix Insurance","type":"Company","amount":0,"hidden":true,"country":"Israel","fullurl":"/company_page/phoenix-insurance","logokey":"$XtEqXGBz2L9gOMMbeFilBmrFoyXOHeiUCuIQa1AIrfenQubsdaKXW8","tagline":"Insurance Company","urlname":"/company_page/phoenix-insurance","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCkieW_Cgw","fundingtype":"Company","leadpartner":null,"investmentid":"0128c9e6-bf99-4d34-ba21-45ff7722cc2d","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$XtEqXGBz2L9gOMMbeFilBmrFoyXOHeiUCuIQa1AIrfenQubsdaKXW8","leadcaption":"","followupcaption":""},{"name":"Federman & Sons","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/federman-sons","logokey":null,"tagline":"","urlname":"/investor_page/federman-sons","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEtezRCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"306a4ac2-a238-4116-bce6-c121ec42f72e","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Bargal R&D Investment","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/bargal-r-d-investment","logokey":null,"tagline":"","urlname":"/investor_page/bargal-r-d-investment","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC4jqbTCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5d73ab93-8361-4dad-bcc0-539a962fe718","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Technorov Holdings","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/technorov-holdings","logokey":null,"tagline":"","urlname":"/investor_page/technorov-holdings","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEu9SfCww","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"612a4724-5e6b-4078-831f-c53bfac217fc","fundingsubtype":"Corporate VC","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Polar Investments","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/polar-investments","logokey":null,"tagline":"","urlname":"/investor_page/polar-investments","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEtYjQCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6d9b8c65-5162-4568-abab-fa6ce1a65bab","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Docor International Management","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/docor","logokey":"$OfHtk8MQpXyjuEfISyRNC2I0FArnwi7SC4uowUIF3xWUco4YnAg2VW","tagline":null,"urlname":"/investor_page/docor","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMnYj5YKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8658f724-71b7-47ac-aaed-34ac3bf01658","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OfHtk8MQpXyjuEfISyRNC2I0FArnwi7SC4uowUIF3xWUco4YnAg2VW","leadcaption":"","followupcaption":""},{"name":"Pontifax","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/Pontifax","logokey":"$8HWp0ziD5Hcmj6wqEIHQTrElz5KthIPEOZM39F7kKUQRFzC0JbmnmH","tagline":null,"urlname":"/investor_page/Pontifax","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOfWjoAKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"9e89afdb-b41c-4799-81c0-8f57455a9b7a","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8HWp0ziD5Hcmj6wqEIHQTrElz5KthIPEOZM39F7kKUQRFzC0JbmnmH","leadcaption":"","followupcaption":""},{"name":"Ziegler Meditech Equity Partners","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/ziegler-meditech-equity-partners","logokey":"$nHMD96loNRn3C8Dcro3zz5Kiq8aEFkqJhlDx6bFQoAyS2dQgOra0Dn","tagline":null,"urlname":"/investor_page/ziegler-meditech-equity-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLWByYgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"eb2575af-9afc-478b-98b8-b6aca88c8ab6","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nHMD96loNRn3C8Dcro3zz5Kiq8aEFkqJhlDx6bFQoAyS2dQgOra0Dn","leadcaption":"","followupcaption":"Follow on "},{"name":"Clal Biotechnology Industries (CBI)","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/cbi","logokey":"$fJl2RfhlVYviq9T0pSOI3rKMQTrLfwIf7Co69YLOBIKRfoeftdbWGk","tagline":null,"urlname":"/investor_page/cbi","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKG0pYwKDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"fcfb365b-af90-4106-8768-b23329055ea9","fundingsubtype":"Corporate VC","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$fJl2RfhlVYviq9T0pSOI3rKMQTrLfwIf7Co69YLOBIKRfoeftdbWGk","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7300000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODElY2aCgw","date":"Nov 2006","amount":"$12M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Ziegler Meditech Equity Partners","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/ziegler-meditech-equity-partners","logokey":"$nHMD96loNRn3C8Dcro3zz5Kiq8aEFkqJhlDx6bFQoAyS2dQgOra0Dn","tagline":null,"urlname":"/investor_page/ziegler-meditech-equity-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLWByYgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"846c5e5a-0f46-4c50-86c9-45c0bd617643","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nHMD96loNRn3C8Dcro3zz5Kiq8aEFkqJhlDx6bFQoAyS2dQgOra0Dn","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":12000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"10/1996","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Interna Therapeutics","logourl":"https://storage.googleapis.com/clean-finder-353810/$wD6ezNFkXzBkFrUNz5UEa6CoCXRREij1ZnsGyEdREfEa0UyMuJNAsf","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$wD6ezNFkXzBkFrUNz5UEa6CoCXRREij1ZnsGyEdREfEa0UyMuJNAsf","seoabout":"Interna Therapeutics is an innovative biotechnology company that developed a transformational delivery technology for macromolecules. \n \nThe pioneering tec...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drug Delivery","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Molecules","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Nanomaterials","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1upgKDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drug Delivery#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Molecules#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA>Nanomaterials#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1upgKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drug Delivery#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Molecules#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA|1:>TechnologyClassificationModel/Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA|2:>TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA/Nanomaterials#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1upgKDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drug Delivery","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drug Delivery"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Molecules","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Molecules"}]},{"title":"Materials & Substances","key":"0-1","path":"TechnologyClassificationModel>Materials & Substances","children":[{"title":"Nanomaterials","key":"0-1-0","path":"TechnologyClassificationModel>Materials & Substances>Nanomaterials"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drug Delivery","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Molecules","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz7ewLDA","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Nanomaterials","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1upgKDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drug Delivery"],"coreTechnology":["Biologicals","Molecules","Materials & Substances","Nanomaterials"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"1rFJEZ4RoQFF2h9xu81iR3I0Py0BiWShfutoqh428PE1iXBf6WfQBq","date":"Aug 2019","amount":"Undisclosed","source":"https://www.tase.co.il/en/market_data/company/1545/securities/delisted","ticker":null,"eventtype":"DelistingEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"","po_label":"Public Offering","duetoacquisition":"","isdelisting":1,"acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":null,"valuationnumber":null},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODwxM_WCgw","date":"Jun 2010","amount":"Undisclosed","source":"","ticker":"APOS","eventtype":"POEvent","valuation":"$238M","investment":[],"capitalraised":"$25M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":25000000,"valuationnumber":238000000}],"privateequityfunding":[{"id":"Q2reUP4PCDJTlLh6fKQCLdiRTP5W11L94MmcoQldCy2HBrtKpHhS0v","date":"Nov 2024","amount":"$10.25M","source":"https://interna.bio/news/needs-authorization-aposense-ltd-secures-10-25-million-funding-round-anchored-by-the-bill-melinda-gates-foundation-announces-merger-with-sirvir-and-name-change-to-interna-therapeuti/","eventtype":"FundingRoundEvent","investment":[{"name":"Bill & Melinda Gates Foundation","type":"Investor","amount":null,"hidden":true,"country":"United States","fullurl":"/investor_page/bill-melinda-gates-foundation-1","logokey":"$p9OelZpbjDTmXC8KXIygAeGkMhOLMYJveju2NbDuZZcXFsP9YIzsEZ.png","tagline":null,"urlname":"/investor_page/bill-melinda-gates-foundation-1","isisraeli":0,"investorid":"59efOBYCZP6VtEgRf9VLpGtlh1KIGD0iqOP0HT0tHj9gxO9ipMI5nC","fundingtype":"Grant Provider","leadpartner":null,"investmentid":"5SNYhMhLfU5b6Ax8aKju0bCaXwPJrX75ZatrSTFQ0RtpqQ9EyuTrCB","fundingsubtype":"Grant Provider","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$p9OelZpbjDTmXC8KXIygAeGkMhOLMYJveju2NbDuZZcXFsP9YIzsEZ.png","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10250000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEu6DRCww","date":"May 2010","amount":"$3M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Ziegler Meditech Equity Partners","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/ziegler-meditech-equity-partners","logokey":"$nHMD96loNRn3C8Dcro3zz5Kiq8aEFkqJhlDx6bFQoAyS2dQgOra0Dn","tagline":null,"urlname":"/investor_page/ziegler-meditech-equity-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLWByYgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"b19fe67a-29ce-4e13-a480-45db20eedf07","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nHMD96loNRn3C8Dcro3zz5Kiq8aEFkqJhlDx6bFQoAyS2dQgOra0Dn","leadcaption":"","followupcaption":"Follow on "},{"name":"Pontifax","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/Pontifax","logokey":"$8HWp0ziD5Hcmj6wqEIHQTrElz5KthIPEOZM39F7kKUQRFzC0JbmnmH","tagline":null,"urlname":"/investor_page/Pontifax","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOfWjoAKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"d80e1d18-5dac-418a-88dc-4b455d55fff8","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8HWp0ziD5Hcmj6wqEIHQTrElz5KthIPEOZM39F7kKUQRFzC0JbmnmH","leadcaption":"","followupcaption":"Follow on "}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODknp7qCAw","date":"Aug 2008","amount":"$7.3M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Phoenix Insurance","type":"Company","amount":0,"hidden":true,"country":"Israel","fullurl":"/company_page/phoenix-insurance","logokey":"$XtEqXGBz2L9gOMMbeFilBmrFoyXOHeiUCuIQa1AIrfenQubsdaKXW8","tagline":"Insurance Company","urlname":"/company_page/phoenix-insurance","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCkieW_Cgw","fundingtype":"Company","leadpartner":null,"investmentid":"0128c9e6-bf99-4d34-ba21-45ff7722cc2d","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$XtEqXGBz2L9gOMMbeFilBmrFoyXOHeiUCuIQa1AIrfenQubsdaKXW8","leadcaption":"","followupcaption":""},{"name":"Federman & Sons","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/federman-sons","logokey":null,"tagline":"","urlname":"/investor_page/federman-sons","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEtezRCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"306a4ac2-a238-4116-bce6-c121ec42f72e","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Bargal R&D Investment","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/bargal-r-d-investment","logokey":null,"tagline":"","urlname":"/investor_page/bargal-r-d-investment","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC4jqbTCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5d73ab93-8361-4dad-bcc0-539a962fe718","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Technorov Holdings","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/technorov-holdings","logokey":null,"tagline":"","urlname":"/investor_page/technorov-holdings","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEu9SfCww","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"612a4724-5e6b-4078-831f-c53bfac217fc","fundingsubtype":"Corporate VC","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Polar Investments","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/polar-investments","logokey":null,"tagline":"","urlname":"/investor_page/polar-investments","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEtYjQCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6d9b8c65-5162-4568-abab-fa6ce1a65bab","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Docor International Management","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/docor","logokey":"$OfHtk8MQpXyjuEfISyRNC2I0FArnwi7SC4uowUIF3xWUco4YnAg2VW","tagline":null,"urlname":"/investor_page/docor","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMnYj5YKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8658f724-71b7-47ac-aaed-34ac3bf01658","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OfHtk8MQpXyjuEfISyRNC2I0FArnwi7SC4uowUIF3xWUco4YnAg2VW","leadcaption":"","followupcaption":""},{"name":"Pontifax","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/Pontifax","logokey":"$8HWp0ziD5Hcmj6wqEIHQTrElz5KthIPEOZM39F7kKUQRFzC0JbmnmH","tagline":null,"urlname":"/investor_page/Pontifax","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOfWjoAKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"9e89afdb-b41c-4799-81c0-8f57455a9b7a","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8HWp0ziD5Hcmj6wqEIHQTrElz5KthIPEOZM39F7kKUQRFzC0JbmnmH","leadcaption":"","followupcaption":""},{"name":"Ziegler Meditech Equity Partners","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/ziegler-meditech-equity-partners","logokey":"$nHMD96loNRn3C8Dcro3zz5Kiq8aEFkqJhlDx6bFQoAyS2dQgOra0Dn","tagline":null,"urlname":"/investor_page/ziegler-meditech-equity-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLWByYgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"eb2575af-9afc-478b-98b8-b6aca88c8ab6","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nHMD96loNRn3C8Dcro3zz5Kiq8aEFkqJhlDx6bFQoAyS2dQgOra0Dn","leadcaption":"","followupcaption":"Follow on "},{"name":"Clal Biotechnology Industries (CBI)","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/cbi","logokey":"$fJl2RfhlVYviq9T0pSOI3rKMQTrLfwIf7Co69YLOBIKRfoeftdbWGk","tagline":null,"urlname":"/investor_page/cbi","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKG0pYwKDA","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"fcfb365b-af90-4106-8768-b23329055ea9","fundingsubtype":"Corporate VC","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$fJl2RfhlVYviq9T0pSOI3rKMQTrLfwIf7Co69YLOBIKRfoeftdbWGk","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7300000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODElY2aCgw","date":"Nov 2006","amount":"$12M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Ziegler Meditech Equity Partners","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/ziegler-meditech-equity-partners","logokey":"$nHMD96loNRn3C8Dcro3zz5Kiq8aEFkqJhlDx6bFQoAyS2dQgOra0Dn","tagline":null,"urlname":"/investor_page/ziegler-meditech-equity-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLWByYgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"846c5e5a-0f46-4c50-86c9-45c0bd617643","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nHMD96loNRn3C8Dcro3zz5Kiq8aEFkqJhlDx6bFQoAyS2dQgOra0Dn","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":12000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[{"id":"O4tCXSWssrMZzssapMmqocje17PqOCvbFIdcEy8C7VgHwjCiKy1Xoj","date":"Nov 2024","amount":"Undisclosed","source":"https://interna.bio/news/needs-authorization-aposense-ltd-secures-10-25-million-funding-round-anchored-by-the-bill-melinda-gates-foundation-announces-merger-with-sirvir-and-name-change-to-interna-therapeuti/","mnatype":"Merger","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"acquiredcompany_mna":"SirVir","acquiredcompany_mna_id":"Qr348JTfPan2SFu8hgnF9teoA3jrZfY5uwKL6oYwkev8rmB0eVKQXX","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/company_page/sirvir","acquiredcompany_mna_logokey":null,"acquiredcompany_mna_urlname":"/company_page/sirvir","acquiredcompany_mna_homepage":"https://aposense.com","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"/assets/empty-state.svg","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"others":[]}}